Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Vitarka Therapeutics Logo
Vitarka Therapeutics Growth Score
9
CB Rank
104405
Heat Score
58
Vitarka Therapeutics develops medical technology and solutions for various types of cancer.
Founded
obfuscation
PrivateSeed London, England, United Kingdom1-10 vitarka.co.uk/
Biotechnology
Health Care
Life Science
Medical
Overview

Vitarka Therapeutics
Total Funding
obfuscation
Growth Score
9
Heat Score
58

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score9
-20 pts
in past quarter
Heat Score 58
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Vitarka Therapeutics

CB Rank
104405
Vitarka Therapeutics develops medical technology and solutions for various types of cancer.
Founded
obfuscation
PrivateSeed London, England, United Kingdom1-10 vitarka.co.uk/
Biotechnology
Health Care
Life Science
Medical

Funding Rounds

Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Vitarka Therapeutics Ltd
Operating Status Active
Company Type For Profit
About the Company
Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.
Contact Email info@vitarka.co.uk
Predictions & Insights

Growth Insight

See this Growth Insight
Vitarka Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

EndoPore®
A drug delivery technology designed to transport therapeutics into the intracellular space, targeting cancer cells while limiting toxicity to normal tissues.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed
obfuscation
Seed Round - Vitarka Therapeutics Logo
Seed Round - Vitarka Therapeutics
2
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Dec 6, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 6, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 18, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 11, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$141.1KThis year, Vitarka Therapeutics is projected to spend $141.1K on IT, according to Aberdeen.

Active Website Tech Count

3Vitarka Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Euro, Pound Sterling, and  Japanese Yen.

Total IP

1Vitarka Therapeutics has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Vitarka Therapeutics's headquarters? Vitarka Therapeutics is located in London, England, United Kingdom.Who invested in Vitarka Therapeutics? Vitarka Therapeutics has 5 investors including SOSV and  SOSV SF & NY (Fka IndieBio).When was the last funding round for Vitarka Therapeutics? Vitarka Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Vitarka Therapeutics's competitors? Alternatives and possible competitors to Vitarka Therapeutics may include Debiopharm Group, BioNTech, and  Halozyme Therapeutics.How much funding has Vitarka Therapeutics raised to date? Vitarka Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|